Muir Kevin has filed 6 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 56500 shares of DELCATH SYSTEMS, INC. ($DCTH) on February 17, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | DELCATH SYSTEMS, INC. | $DCTH | Muir Kevin | GM INTERVENTIONAL ONCOLOGY | A | Stock Option (Right to Buy) | 56500 | $0.00 | 56,500.0000 | 40,056,814 | 9999.99% | 0.14% |
| Feb. 17, 2026 | DELCATH SYSTEMS, INC. | $DCTH | Muir Kevin | GM INTERVENTIONAL ONCOLOGY | A | Restricted Stock Units | 28250 | $0.00 | 28,250.0000 | 40,056,814 | 9999.99% | 0.07% |
| Feb. 7, 2025 | DELCATH SYSTEMS, INC. | $DCTH | Muir Kevin | GM INTERVENTIONAL ONCOLOGY | A | Stock Option (Right to Buy) | 113000 | $0.00 | 113,000.0000 | 28,511,393 | 9999.99% | 0.40% |
| March 19, 2024 | DELCATH SYSTEMS, INC. | $DCTH | Muir Kevin | GM INTERVENTIONAL ONCOLOGY | A | Common Stock | 13441 | $3.72 | 18,582.0000 | 16,229,931 | 261.45% | 0.08% |
| Feb. 12, 2024 | DELCATH SYSTEMS, INC. | $DCTH | Muir Kevin | VP COMMERCIAL OPERATIONS | A | Stock Option (Right to Buy) | 100500 | $0.00 | 100,500.0000 | 16,229,931 | 9999.99% | 0.62% |
| Feb. 8, 2023 | DELCATH SYSTEMS, INC. | $DCTH | Muir Kevin | VP COMMERCIAL OPERATIONS | A | Stock Option (Right to Buy) | 46800 | $0.00 | 46,800.0000 | 0 | 9999.99% | 0.00% |